Abstract

Many immune‑related Adverse Events (irAEs) resolve after discontinuation of Immune Checkpoint Inhibitors (ICIs) and treatment with immunosuppression, most commonly corticosteroids. However, some irAEs can recur or persist after discontinuation of ICIs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call